Estrogen-lowering drugs reduce mastectomy rates for breast cancer patients
In the first large trial of its kind in the United States, researchers have shown that estrogen-lowering drugs can shrink tumors and reduce mastectomy rates for patients with stage 2 or 3 breast cancer.
Nobel Laureate Kenneth Arrow discusses economics of new malarial drugs, Oct. 21
Nobel Laureate Kenneth J. Arrow will discuss “The Economics of New Antimalarial Drugs” at 2:30 p.m. Oct. 21 in the Bryan Cave Courtroom, Anheuser-Busch Hall. Arrow, a longtime professor of economics at Stanford University, recently chaired a National Institute of Medicine committee that issued a report titled “Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance.” Malaria, along with tuberculosis and HIV/AIDS, is one of the big three global killers of the world’s poorest people.